184 related articles for article (PubMed ID: 28707391)
21. Sentinel lymph node biopsy in melanoma: controversies and current guidelines.
Durham AB; Wong SL
Future Oncol; 2014 Feb; 10(3):429-42. PubMed ID: 24559449
[TBL] [Abstract][Full Text] [Related]
22. Risk stratification of sentinel node-positive melanoma patients defines surgical management and adjuvant therapy treatment considerations.
Verver D; van Klaveren D; van Akkooi ACJ; Rutkowski P; Powell BWEM; Robert C; Testori A; van Leeuwen BL; van der Veldt AAM; Keilholz U; Eggermont AMM; Verhoef C; Grünhagen DJ
Eur J Cancer; 2018 Jun; 96():25-33. PubMed ID: 29660597
[TBL] [Abstract][Full Text] [Related]
23. High positive sentinel node identification rate by EORTC melanoma group protocol. Prognostic indicators of metastatic patterns after sentinel node biopsy in melanoma.
van Akkooi AC; de Wilt JH; Verhoef C; Graveland WJ; van Geel AN; Kliffen M; Eggermont AM
Eur J Cancer; 2006 Feb; 42(3):372-80. PubMed ID: 16403622
[TBL] [Abstract][Full Text] [Related]
24. Radioguided sentinel lymph node biopsy in malignant cutaneous melanoma.
Mariani G; Gipponi M; Moresco L; Villa G; Bartolomei M; Mazzarol G; Bagnara MC; Romanini A; Cafiero F; Paganelli G; Strauss HW
J Nucl Med; 2002 Jun; 43(6):811-27. PubMed ID: 12050328
[TBL] [Abstract][Full Text] [Related]
25. Prognostic value of sentinel node biopsy in 327 prospective melanoma patients from a single institution.
Roulin D; Matter M; Bady P; Liénard D; Gugerli O; Boubaker A; Bron L; Lejeune FJ
Eur J Surg Oncol; 2008 Jun; 34(6):673-9. PubMed ID: 17825518
[TBL] [Abstract][Full Text] [Related]
26. Predictors of sentinel lymph node positivity in thin melanoma using the National Cancer Database.
Conic RRZ; Ko J; Damiani G; Funchain P; Knackstedt T; Vij A; Vidimos A; Gastman BR
J Am Acad Dermatol; 2019 Feb; 80(2):441-447. PubMed ID: 30240775
[TBL] [Abstract][Full Text] [Related]
27. Radioguided sentinel lymph node biopsy in patients with malignant cutaneous melanoma: the nuclear medicine contribution.
Mariani G; Erba P; Manca G; Villa G; Gipponi M; Boni G; Buffoni F; Suriano S; Castagnola F; Bartolomei M; Strauss HW
J Surg Oncol; 2004 Mar; 85(3):141-51. PubMed ID: 14991886
[TBL] [Abstract][Full Text] [Related]
28. [Sentinel node biopsy. What are the facts?].
Möhrle M; Breuninger H
Hautarzt; 2005 May; 56(5):441-7. PubMed ID: 15887051
[TBL] [Abstract][Full Text] [Related]
29. Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial.
Leiter U; Stadler R; Mauch C; Hohenberger W; Brockmeyer N; Berking C; Sunderkötter C; Kaatz M; Schulte KW; Lehmann P; Vogt T; Ulrich J; Herbst R; Gehring W; Simon JC; Keim U; Martus P; Garbe C;
Lancet Oncol; 2016 Jun; 17(6):757-767. PubMed ID: 27161539
[TBL] [Abstract][Full Text] [Related]
30. [Cutaneous melanoma and sentinel lymph node biopsy: where are we today?].
Girod A; Salmon R; Rodriguez J
Bull Cancer; 2007 Jul; 94(7):687-91. PubMed ID: 17723951
[TBL] [Abstract][Full Text] [Related]
31. Validity of ultrasound-guided aspiration needle biopsy in the diagnosis of micrometastases in sentinel lymph nodes in patients with cutaneous melanoma.
Šijan G; Kozarski J; Stepić N; Milojević S; Stefanović D; Tatomirović Ž; Jauković L; Vesanović S; Rajović M
Vojnosanit Pregl; 2016 Oct; 73(10):934-40. PubMed ID: 29328105
[TBL] [Abstract][Full Text] [Related]
32. Identifying the Sentinel Lymph Node in Patients with Cutaneous Melanoma - Preliminary Report of a Private Clinic in Bucharest.
Bobirca F; Coltoiu C; Jauca C; Tebeica T; Bobirca A; Pumnea A; Leventer M
Chirurgia (Bucur); 2020; 115(4):476-485. PubMed ID: 32876021
[No Abstract] [Full Text] [Related]
33. A review of sentinel lymph node biopsy for thin melanoma.
Joyce KM; McInerney NM; Joyce CW; Jones DM; Hussey AJ; Donnellan P; Kerin MJ; Kelly JL; Regan PJ
Ir J Med Sci; 2015 Mar; 184(1):119-23. PubMed ID: 25366817
[TBL] [Abstract][Full Text] [Related]
34. High discordance rate in assessing sentinel node positivity in cutaneous melanoma: Expert review may reduce unjustified adjuvant treatment.
El Sharouni MA; Laeijendecker AE; Suijkerbuijk KP; Witkamp AJ; Sigurdsson V; van Diest PJ; van Gils CH; Blokx WA
Eur J Cancer; 2021 May; 149():105-113. PubMed ID: 33848712
[TBL] [Abstract][Full Text] [Related]
35. The sentinel lymph node spread determines quantitatively melanoma seeding to non-sentinel lymph nodes and survival.
Ulmer A; Dietz K; Werner-Klein M; Häfner HM; Schulz C; Renner P; Weber F; Breuninger H; Röcken M; Garbe C; Fierlbeck G; Klein CA
Eur J Cancer; 2018 Mar; 91():1-10. PubMed ID: 29316475
[TBL] [Abstract][Full Text] [Related]
36. Lymphoscintigraphy and sentinel lymph node biopsy, in cutaneous melanoma staging and treatment decisions.
Jaukovic L; Sijan G; Rajović M; Kandolf-Sekulovic L; Radulovic M; Mijuskovic Z; Zolotarevski L; Ajdinovic B; Novakovic M
Hell J Nucl Med; 2015; 18(2):146-51. PubMed ID: 26187215
[TBL] [Abstract][Full Text] [Related]
37. Sentinel node metastasis mitotic rate (SN-MMR) as a prognostic indicator of rapidly progressing disease in patients with sentinel node-positive melanomas.
Baum C; Weiss C; Gebhardt C; Utikal J; Marx A; Koenen W; Géraud C
Int J Cancer; 2017 Apr; 140(8):1907-1917. PubMed ID: 27935036
[TBL] [Abstract][Full Text] [Related]
38. No non-sentinel node involvement in melanoma patients with limited Breslow thickness and low sentinel node tumour load.
Bogenrieder T; van Dijk MR; Blokx WA; Ramrath K; Seldenrijk K; Stolz W; van Diest PJ
Histopathology; 2011 Aug; 59(2):318-26. PubMed ID: 21884211
[TBL] [Abstract][Full Text] [Related]
39. Sentinel lymph node biopsy from the vantage point of an oncologic surgeon.
Wilson LL
Clin Dermatol; 2009; 27(6):594-6. PubMed ID: 19880046
[TBL] [Abstract][Full Text] [Related]
40. [Viewpoint of the Dutch Melanoma Working Group regarding sentinel lymph node biopsy: prognostic but not therapeutic implications].
Kruit WH;
Ned Tijdschr Geneeskd; 2008 Mar; 152(10):574-6. PubMed ID: 18402325
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
